Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients
- PMID: 9187598
- DOI: 10.1097/00003246-199705000-00014
Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients
Abstract
Objective: To evaluate the effects of pentoxifylline on hemodynamics and systemic oxygenation in septic and nonseptic critically ill patients.
Design: Prospective clinical investigation.
Setting: Intensive care unit (ICU) of a university hospital.
Patients: Nineteen critically ill patients were included in the study 1 to 4 days after their admission to the ICU. A systemic inflammatory response syndrome was present in 12 patients, fulfilling at least two of the American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference criteria. The other seven patients did not fulfill these criteria and were classified as nonseptic.
Interventions: All patients were mechanically ventilated. The dosage of catecholamines was kept constant during the entire study period and at least during 15 mins before the start of the study. In both study groups, pulmonary and radial artery catheters were inserted and 5 mg/kg of pentoxifylline (diluted in 300 mL of physiologic saline) was intravenously administered over a period of 180 mins at a rate of 100 mL/hr.
Measurements and main results: Hemodynamic variables, oxygen transport (DO2), oxygen uptake (VO2), and oxygen extraction ratio were determined before pentoxifylline, after 2.5 mg/kg of pentoxifylline, after 5 mg/kg of pentoxifylline, and 60 mins after the termination of pentoxifylline. Repeated-measures analysis of variance and Mann-Whitney test were used for statistical analysis. At baseline, there were significant differences between the septic and the nonseptic groups in mean pulmonary arterial pressure (septic: 31 +/- 5 mm Hg; nonseptic: 26 +/- 7 mm Hg, p < .05), and pulmonary vascular resistance index (PVRI) (septic: 344 +/- 121 dyne.sec/ cm5.m2; nonseptic: 233 +/- 100 dyne.sec/cm5.m2, p < .05). In the septic group, significant increases in heart rate and cardiac index were observed. Systemic vascular resistance index and PVRI decreased. No significant changes in hemodynamic variables occurred in the nonseptic group. In both groups, DO2 and VO2 increased significantly, while oxygen extraction ratio remained unchanged.
Conclusions: The administration of pentoxifylline to septic patients results in a significant improvement in hemodynamic performance compared with critically ill nonseptic patients. The better hemodynamic state is accompanied by an increase in DO2 and VO2 with unchanged oxygen extraction ratio.
Similar articles
-
Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.Chest. 1996 May;109(5):1291-301. doi: 10.1378/chest.109.5.1291. Chest. 1996. PMID: 8625682 Clinical Trial.
-
Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study.Crit Care Med. 1993 Dec;21(12):1868-75. doi: 10.1097/00003246-199312000-00014. Crit Care Med. 1993. PMID: 8252892 Clinical Trial.
-
Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome.Crit Care Med. 1997 Jun;25(6):926-36. doi: 10.1097/00003246-199706000-00007. Crit Care Med. 1997. PMID: 9201043 Clinical Trial.
-
Opening the microcirculation: can vasodilators be useful in sepsis?Intensive Care Med. 2002 Sep;28(9):1208-17. doi: 10.1007/s00134-002-1407-2. Epub 2002 Jul 27. Intensive Care Med. 2002. PMID: 12209267 Review.
-
[Anti-inflammatory effects of pentoxifylline: importance in cardiac surgery].Anaesthesist. 2009 Nov;58(11):1136-43. doi: 10.1007/s00101-009-1626-9. Anaesthesist. 2009. PMID: 19890615 Review. German.
Cited by
-
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.Curr Med Chem. 2008;15(19):1911-24. doi: 10.2174/092986708785132942. Curr Med Chem. 2008. PMID: 18691048 Free PMC article. Review.
-
Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates.Cochrane Database Syst Rev. 2023 Jun 20;6(6):CD004205. doi: 10.1002/14651858.CD004205.pub4. Cochrane Database Syst Rev. 2023. PMID: 37338074 Free PMC article.
-
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?Int J Mol Sci. 2021 Feb 16;22(4):1929. doi: 10.3390/ijms22041929. Int J Mol Sci. 2021. PMID: 33669167 Free PMC article. Review.
-
Adjunctive drug treatment in severe hypoxic respiratory failure.Drugs. 1999 Sep;58(3):429-46. doi: 10.2165/00003495-199958030-00004. Drugs. 1999. PMID: 10493271 Review.
-
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005. Crit Care Clin. 2011. PMID: 21742216 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical